Blood test could slash unnecessary antibiotics in pancreatitis patients
NCT ID NCT07308600
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a new blood test that combines genetic sequencing and immune response analysis to quickly tell if dead pancreatic tissue has become infected. Researchers will enroll 200 patients with severe pancreatitis across four hospitals. If accurate, this test could help doctors start targeted antibiotics earlier and reduce unnecessary antibiotic use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- blood test combining metagenomic sequencing and host response analysis
- What this could lead to
- If successful, this blood test could provide a faster, more accurate way to diagnose infected pancreatic necrosis, helping doctors start the right antibiotics sooner and avoid unnecessary ones.
- What could go wrong
- This is an early-stage study with only 200 participants, so results may not apply to everyone. The test might not be accurate enough in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE NECROTIZING PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.